Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms
- PMID: 20023065
- DOI: 10.1177/0883073809348355
Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms
Abstract
The magnitude and causes of death among a cohort of children with epilepsy were determined. A follow-up study with a population-based cohort of 10-year-old children in the metropolitan Atlanta area with epilepsy was conducted. The National Death Index and linkage to State of Georgia death certificates were used to identify deaths. The authors estimated the expected numbers of deaths by applying mortality rates adjusted by age, race, and sex for the entire state of Georgia to the population for the follow-up period. Among the 688 children who were in the final epilepsy cohort, 64 deaths occurred; 20.6 deaths were expected (mortality ratio adjusted for age, race, and sex = 3.11). The mortality ratios for children with Lennox-Gastaut syndrome and infantile spasms were 13.92 and 11.91, respectively. Children and adolescents with epilepsy, especially those with Lennox-Gastaut syndrome or infantile spasms, have an increased risk of death.
Similar articles
-
[Treatment of West syndrome].Acta Med Croatica. 2005;59(1):19-29. Acta Med Croatica. 2005. PMID: 15813352 Croatian.
-
Factors influencing the evolution of West syndrome to Lennox-Gastaut syndrome.Pediatr Neurol. 2009 Aug;41(2):111-3. doi: 10.1016/j.pediatrneurol.2009.03.006. Pediatr Neurol. 2009. PMID: 19589458
-
Lennox-Gastaut syndrome symptomatic to hypothalamic hamartoma: evolution and long-term outcome following surgery.Pediatr Neurol. 2013 Jul;49(1):25-30. doi: 10.1016/j.pediatrneurol.2013.03.016. Pediatr Neurol. 2013. PMID: 23827423
-
Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy.Epilepsia. 2004;45 Suppl 5:2-4. doi: 10.1111/j.0013-9580.2004.05002.x. Epilepsia. 2004. PMID: 15283704 Review.
-
The epidemiology of the epilepsies in children.Ment Retard Dev Disabil Res Rev. 2002;8(3):171-81. doi: 10.1002/mrdd.10035. Ment Retard Dev Disabil Res Rev. 2002. PMID: 12216061 Review.
Cited by
-
Lennox-Gastaut syndrome. Management update.Neurosciences (Riyadh). 2015 Jul;20(3):207-12. doi: 10.17712/nsj.2015.3.20140677. Neurosciences (Riyadh). 2015. PMID: 26166587 Free PMC article. Review.
-
Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.Exp Neurol. 2023 Feb;360:114294. doi: 10.1016/j.expneurol.2022.114294. Epub 2022 Dec 6. Exp Neurol. 2023. PMID: 36493860 Free PMC article.
-
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.Neuropsychiatr Dis Treat. 2017 Apr 20;13:1131-1140. doi: 10.2147/NDT.S115996. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28461749 Free PMC article. Review.
-
Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families.Front Genet. 2021 Jan 20;11:590924. doi: 10.3389/fgene.2020.590924. eCollection 2020. Front Genet. 2021. PMID: 33584793 Free PMC article.
-
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.Adv Exp Med Biol. 2021;1264:93-110. doi: 10.1007/978-3-030-57369-0_7. Adv Exp Med Biol. 2021. PMID: 33332006 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical